Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.
about
Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysisCoronary artery revascularization in patients with diabetes mellitusComparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled TrialsShort term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?Efficacy and safety of drug-eluting stents in the real world: 8-year follow-up.Second- versus first-generation drug-eluting stents for diabetic patients: a meta-analysis.The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis.Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives.Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysisEffects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography.Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.Metformin impairs endothelialization after placement of newer generation drug eluting stentsFive-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trialStent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematiClinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients--interim results from multicenter post market surveillance registry in India.Comparison of drug-eluting and bare-metal stents in patients with diabetes undergoing primary percutaneous coronary intervention: what is the evidence?Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.Systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials.Coronary stents: historical development, current status and future directions.New-generation drug-eluting stents: focus on Xience V® everolimus-eluting stent and Resolute® zotarolimus-eluting stent.Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced?Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes: a meta-analysis.Drug-eluting versus bare-metal coronary stents: where are we now?Drug-eluting stent outcomes in diabetes.Choosing the right coronary stent in the modern era.Revascularization strategies for patients with stable coronary artery disease.Percutaneous coronary intervention in patients with diabetes: current concepts and future directions.Evolution of coronary stents in patients with diabetes: are clinical outcomes still improving?Revascularization in patients with diabetes: PCI or CABG or none at all.Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes.Long-term (2-5 years) adverse clinical outcomes associated with ZES versus SES, PES and EES: A Meta-Analysis.Controversies surrounding percutaneous coronary intervention in the diabetic patient.Revascularization in complex multivessel coronary artery disease after FREEDOM. Is there an indication for PCI and drug-eluting stents?Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.Second-generation versus first-generation drug-eluting stents in patients with and without diabetes mellitus: pooled analysis from the RESET and NEXT trials.Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease.Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
P2860
Q26786265-194C5EE4-1A4E-49BA-A8BF-E1954E877B68Q26824002-D1DED6AA-9441-4DC6-98BE-ABC5B46DDBDEQ28551554-3396E9CC-4FAF-4BE5-96F9-19C88CCB6EC1Q30241829-8DCEB6EA-2D7E-4095-ADB6-1CDE96131390Q33582307-4EACCE8A-80DD-4302-A597-BD59487A0D84Q34319885-C37150F1-E979-4F01-BAB3-CC73A851974CQ34662245-B93A547F-93CB-4ADD-BADE-D7BC4E3F98CDQ34996907-CDFA5C34-5728-4C5C-B8CD-5B1F56999D3DQ35193488-E7C171DB-6F8C-44A4-AFBA-D6FAB955B34AQ36239147-7F8B4522-4C42-4EC1-8B25-92CEE07C2458Q36370257-A928AF62-2598-47A8-A753-4307741C8E1CQ36923284-008691D3-A500-4921-9EBD-C1F98FDEE362Q36995923-52E87AB0-26A0-4D7B-8AA0-42FA88CAC9EBQ37070230-6C91B4B2-2AC8-4788-9D0A-312AEA41D0D7Q37228675-32F25B04-E666-4BA1-B629-9291FF44643CQ37328131-E89872D3-F668-4BE9-BE74-B17B6A48E8F3Q37388164-3A2BA1F0-50BD-4581-B5EE-19E9CB6B0C9DQ37401233-0B49693A-A9D8-47E9-AD0E-5DD28FE37EE2Q37403027-22FDA901-0B8C-4A45-97D3-033FEE4BC622Q37502920-6F89734C-077A-4E5C-96E4-BBAAF329B032Q38084136-DD1EE1E3-E00E-4FA4-9856-17C915EC5E3BQ38093501-867CAA8F-1A7B-4C2A-BE7C-67723AA20493Q38100805-2753B6EC-BAB8-440E-A534-AD40CD5C68A9Q38101961-13AC43EB-3860-4959-AF2E-DBFCA028934FQ38161765-4650D0F1-1C4B-42A4-B27D-652AACDD7D35Q38162864-650F2010-4F7C-45B1-8A00-790510029751Q38171868-19AB3D4F-741C-411D-9E3E-09DCF2DB62E8Q38194095-ACF1E9BB-7410-455D-96FD-723A273BB6B6Q38201161-E91E111F-24EC-46B9-AF2E-05B598C16D6FQ38216000-04864569-EDF6-49DF-A884-D1805D2C44F9Q38221101-965D6E40-7220-4B1E-9D55-E7514CBE10BFQ38353639-7B309974-53CD-47D8-94F4-7A3A79739DFAQ38387683-0A47A123-E3D8-4AEB-BD05-FD5B0BDEAC3EQ38651885-5D08CCB8-9D10-4CA1-B823-C346D88D270EQ38720113-1EB9C388-1893-42A3-AEDC-FA01FE82C758Q38799167-0534F551-D03F-475B-BEB2-5DA6B85420EFQ38969182-F89B64D8-D6BD-48C6-BDBA-E8F287E99137Q38985165-3745EA7B-C70B-43FD-B2C8-2CBDF625F675Q39410697-7B2C161C-0FBA-4B3E-A866-80F2246EDE43Q39488157-2A93431B-A818-4D82-9BAD-C2AFB7EC5F84
P2860
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Outcomes with various drug elu ...... low-up from randomised trials.
@ast
Outcomes with various drug elu ...... low-up from randomised trials.
@en
type
label
Outcomes with various drug elu ...... low-up from randomised trials.
@ast
Outcomes with various drug elu ...... low-up from randomised trials.
@en
prefLabel
Outcomes with various drug elu ...... low-up from randomised trials.
@ast
Outcomes with various drug elu ...... low-up from randomised trials.
@en
P2093
P2860
P50
P356
P1433
P1476
Outcomes with various drug elu ...... llow-up from randomised trials
@en
P2093
David O Williams
Donald E Cutlip
Frederick Feit
Mario Fusaro
Nicholas Amoroso
Sunil Kumar
P2860
P356
10.1136/BMJ.E5170
P407
P577
2012-08-10T00:00:00Z